tiprankstipranks
Advertisement
Advertisement

BFRI Stock Latest News

Is BFRI a Buy, Before Earnings?
Pre-EarningsIs BFRI a Buy, Before Earnings?
4d ago
BFRI
Biofrontera Earnings Call: Profits Rise, Risks Remain
PremiumCompany Announcements
Biofrontera Earnings Call: Profits Rise, Risks Remain
2M ago
BFRI
Biofrontera reports Q4 revenue $17.1M vs. $12.6M last year
PremiumThe Fly
Biofrontera reports Q4 revenue $17.1M vs. $12.6M last year
2M ago
BFRI
Biofrontera, Inc. (BFRI) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Biofrontera, Inc. (BFRI) Q4 Earnings Cheat Sheet
2M ago
BFRI
Biofrontera Reports Positive Phase 2b Acne Trial Results
PremiumCompany Announcements
Biofrontera Reports Positive Phase 2b Acne Trial Results
2M ago
8K
BFRI
Biofrontera reports Phase 2b results of Ameluz PDT in acne vulgaris
PremiumThe FlyBiofrontera reports Phase 2b results of Ameluz PDT in acne vulgaris
2M ago
BFRI
Biofrontera Wins Key PTAB Ruling in Sun Patent Dispute
Premium
Company Announcements
Biofrontera Wins Key PTAB Ruling in Sun Patent Dispute
2M ago
8K
BFRI
Biofrontera reports USPTO decision on Sun Pharma’s challenged claims
Premium
The Fly
Biofrontera reports USPTO decision on Sun Pharma’s challenged claims
2M ago
BFRI
Biofrontera announces database lock of Phase 1 PK study of Ameluz
PremiumThe Fly
Biofrontera announces database lock of Phase 1 PK study of Ameluz
3M ago
BFRI
Biofrontera announces FDA acceptance of sNDA for Ameluz PDT
PremiumThe Fly
Biofrontera announces FDA acceptance of sNDA for Ameluz PDT
3M ago
BFRI
Biofrontera Reports Positive Phase 3 Ameluz PDT Results
PremiumCompany Announcements
Biofrontera Reports Positive Phase 3 Ameluz PDT Results
3M ago
8K
BFRI
Biofrontera announces positive Phase 3 results for Ameluz PDT
PremiumThe Fly
Biofrontera announces positive Phase 3 results for Ameluz PDT
3M ago
BFRI
Biofrontera reports preliminary Q4 revenue $17M-$17.5M
PremiumThe FlyBiofrontera reports preliminary Q4 revenue $17M-$17.5M
4M ago
BFRI
Biofrontera announces data base locks for two clinical studies
Premium
The Fly
Biofrontera announces data base locks for two clinical studies
4M ago
BFRI
Biofrontera Receives Nasdaq Notice on Bid Price Noncompliance
Premium
Company Announcements
Biofrontera Receives Nasdaq Notice on Bid Price Noncompliance
4M ago
8K
BFRI
Biofrontera completes transfer of Ameluz, RhodoLED FDA approval
PremiumThe Fly
Biofrontera completes transfer of Ameluz, RhodoLED FDA approval
5M ago
BFRI
Biofrontera Inc. files to sell 4M shares of common stock for holders
PremiumThe Fly
Biofrontera Inc. files to sell 4M shares of common stock for holders
5M ago
BFRI
Biofrontera completes final patient visit in Phase 1 PK study of Ameluz gel
PremiumThe Fly
Biofrontera completes final patient visit in Phase 1 PK study of Ameluz gel
5M ago
BFRI
Biofrontera files sNDA for Ameluz-PDT in treatment of sBCC
PremiumThe Fly
Biofrontera files sNDA for Ameluz-PDT in treatment of sBCC
5M ago
BFRI
Biofrontera Inc. Reports Q3 2025 Results and Strategic Moves
PremiumCompany AnnouncementsBiofrontera Inc. Reports Q3 2025 Results and Strategic Moves
6M ago
BFRI
Biofrontera, Inc. Navigates Mixed Earnings Call
Premium
Company Announcements
Biofrontera, Inc. Navigates Mixed Earnings Call
6M ago
BFRI
Biofrontera reports Q3 EPS (62c) vs (98c) last year
Premium
The Fly
Biofrontera reports Q3 EPS (62c) vs (98c) last year
6M ago
BFRI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >